Sonova Reports Strong FY 2025/26 Growth, Led by Infinio Platform

✦ Clinical Takeaway ✦

No actionable change — this is a corporate financial report; it signals market momentum for Phonak/Infinio products but contains no clinical guidance.

✦ Why It Matters ✦

Sonova's strong financial performance and Infinio platform growth signal continued premium-tier investment in hearing aid technology, which shapes product availability and competitive pricing across the audiology market.

✦ Key Points ✦

01Sonova reported strong revenue growth for fiscal year 2025/26.
02The Infinio hearing aid platform was cited as a primary growth driver.
03Results reflect broader market momentum for Sonova's Phonak and related brands.
04Financial performance may influence future R&D investment and product roadmap decisions.
05Report sourced from trade coverage on HearingTracker, not Sonova's own channels.

✦ Claims & Evidence ✦

ClaimEvidenceSupport

Sonova achieved strong financial growth in FY 2025/26.

press releaseunclear

Growth was led in part by momentum from the Infinio hearing aid platform.

press releasepartially supported

✦ Related stories ✦

MedWatch·Industry news·Business & finance·6d ago

WS Audiology puts faith in own brands despite Italian-Danish megadeal

A potential Amplifon–GN deal would be one of the largest consolidations in hearing care history, and WSA's response strategy may affect product choices and brand availability for clinics and dispensers globally.

MedWatch·Industry news·Business & finance·11d ago

Italian owners evoke "mixed feelings" at GN

A change in ownership of a major hearing aid manufacturer could reshape product development priorities, brand identity, and supply relationships across the global audiology market.

Doctor Cliff, AuD·Video·Business & finance·2w ago

Why Did Phonak Hearing Aids Leave Costco?

Dr. Cliff recounts the history of Phonak's 2014 entry into Costco retail channels and the subsequent withdrawal of the brand by parent company Sonova in the early 2020s.

The Hearing Journal Podcast·Podcast·Business & finance·2y ago

Ep. 2023-08: BONUS! Judy Huch, AuD, on Business Savvy for Practice Owners

Bonus aftershow with Dr. Judy Huch covering how audiology practice owners can manage employee embezzlement and implement theft-prevention measures in their clinics.

MedWatch·Industry news·Business & finance·6d ago

WS Audiology lags behind in key business area and goes all in on next wave of products

WS Audiology's performance struggles and product pipeline timing signal potential shifts in hearing aid availability, pricing, and competitive dynamics that clinic owners and dispensers should monitor.

Audiology Worldnews·Industry news·Business & finance·6d ago

WSA clings to growth as hearing aid market slowdown continues

Slowing market growth at one of the world's largest hearing aid groups signals broader industry headwinds that could affect device availability, pricing, and R&D investment across the field.

MedWatch·Industry news·Business & finance·7d ago

GN partner move could reshape US hearing aid market: “A real game-changer"

The GN–NationsBenefits tie-up could accelerate consolidation of the US discount hearing aid retail channel, reshaping competitive dynamics for independent clinics and dispenser networks.

MedWatch·Industry news·Business & finance·5d ago

WS Audiology moves closer to IPO as debt and interest costs fall

A potential IPO for WS Audiology would mark a major shift in the ownership structure of one of the hearing aid industry's biggest players, with possible downstream effects on pricing, product strategy, and market competition.